ANTIDEPRESSANTS: 42% of suicides in One Indiana County Were on Antidepressants

NOTE FROM Ann Blake-Tracy (www.drugawareness.org):
Note the title of this article and how they are blaming increased
suicide with the economy. The economy does increase suicide in several ways but
the two most common denominators in the economy doing this is that these drugs
are more often prescribed due to depression being more common with a poor
economy and people already on antidepressants not being able to keep up their
insurance so that they can afford the drugs thus forcing people into abrupt
withdrawal. The FDA has already warned that abrupt withdrawal from an
antidepressant can produce suicide, hostility or psychosis.
How, how, how can there be such a high rate of suicide
associated with the use of antidepressants and the article STILL complain that
people have a stigma about “getting help” which in their terms means getting
drugged with an antidepressant?! Oh yes, and we are suppose to believe that
counseling is supposed to help that be less fatal.
These drugs have been shown over and over again to increase
the rate of suicide. But as Hitler said, if you tell a lie often enough people
will believe it. Drug companies have that practice perfected. They will tell you
that black is white and day is night all day long.
Although the report shows a high rate of suicide (42%)
associated with antidepressant use, what is NOT addressed is how many had
recently been taking antidepressants and were in withdrawal which can cause
additional suicidal risks.
___________________________________
Second paragraph from the end reads:  “Of the 17
deaths in the first half of 2009, seven people were taking antidepressant
medication
, but only one was seeing a counselor. Chappell and Groves
said studies show doing both works best.”

SSRI Stories note:  So

forty-two percent of the people who committed suicide were taking
an antidepressant.  This is an exceedingly high
number.

http://www.courierpress.com/news/2009/sep/07/economy-related-suicides-up/

Economy-related suicides up

Groves: Overall numbers consistent with 2008

  • By Gavin
    Lesnick

  • Posted September 7, 2009 at 11:40 p.m. , updated September 8, 2009 at 9:35
    a.m.
Source: Vanderburgh County Coroner’s Office

EVANSVILLE ­
Vanderburgh County had the same number of suicides through the first half of

this year as it did in the first six months of 2008, though officials say there
has been a marked increase in self-inflicted deaths tied to the faltering
economy.

Of the 17 suicides reported through June 30, six of them
occurred after the person lost his job.

That compares with only one

job-related suicide in the first half of 2008.

Coroner Annie Groves
called it a big concern, especially given the recent news that Whirlpool will
shut down next year, taking 1,100 jobs with it. “When you lose your job, you
lose your home, you lose hope,” Groves said. “That worries me with this
economy.”

The coroner’s office recently released data on suicides in
advance of Suicide Awareness and Prevention Week, which continues through
Saturday in Evansville. It ends with the LifeSavers Walk, an annual event that
raises awareness and funds for addressing the suicide problem. Registration
starts at 8 a.m. Saturday at the Evansville State Hospital, 3400 Lincoln
Ave.

Local efforts toward combating suicides grew in 2007, when
Vanderburgh County ended the year with a record 40 self-inflicted deaths.

The numbers went down slightly in 2008, when 38 were reported by year’s
end, and are on pace this year to finish down again.

In addition to the
increase in job-related suicides, Groves said there also has been a steady
increase in self-inflicted deaths by people ages 20 to 39. There were 11 such
deaths in the first six months of the year compared with just five during that
span last year, 14 in all of 2008 and 16 in all of 2007.

“That’s an area
I’m very concerned about,” Groves said. “… It used to be 50 to 59 was our
higher ones.”

The 17 deaths recorded through the end of June include only
confirmed suicides.

Groves said there likely are six more suicides among
14 cases officially ruled accidental overdoses, but that a lack of hard evidence
prevents her from ruling those deaths intentional.

But on another front,
the numbers could be construed as artificially high: The 17 self-inflicted
deaths include seven people who committed a suicidal act in another county but
died here after being airlifted to an Evansville hospital.

In any event,
Groves said seeing the numbers come down from the record-setting 2007 figures is
a good sign.

She credits the dip with multiple prevention efforts: the
walk, frequent classes that teach the signs and symptoms of suicide and
brochures and billboards that increase awareness.

“We’re so busy focusing

on how many we’ve lost, we sometimes forget to focus on how many we’ve saved,”
Groves said.

Janie Chappell, chairwoman of the Southwestern Indiana
Suicide Prevention Coalition, said awareness efforts increasingly will focus on
encouraging people suffering from depression to seek medication and
counseling.

Of the 17 deaths in the first half of 2009, seven people were

taking antidepressant medication, but only one was seeing a counselor. Chappell
and Groves said studies show doing both works best.

“But there’s still so
much stigma surrounding mental health, people are reluctant to get help,”
Chappell said.

465 total views, no views today

Strattera Deaths (German TV Request) False Reports from Eli Lilly

Wed Nov 12, 2008

We have received a request from a German TV crew who is doing a special on Lilly’s newer ADHD medication, Stratera. These investigative reporters from Germany are doing a 45 minute piece and looking for experiences of tragedy /suicide or severe adverse reactions in children treated for ADHD with this drug. I know we have had reports, but I do not keep close track anymore of which drug is involved after so many cases because all these drugs work basically the same way. An antidepressant is an antidepressant no matter what you callmit or what you prescribe it for or how you explain its supposed uniqueness. So if you or someone you know has been through a Strattera-induced nightmareand would be willing to help get some exposure of this in the press, please get in touch with me so that I can put you in touch the reporters.

O nce you read the following article on Strattera deaths you will see how very important it is to get information about this drug out to the public –

especially throughout the UK and Europe. What is going on here IS CRIMINAL!!
And here is just one example out of the article below that is full of data on how
the government agency in the UK who oversees these drugs is ignoring
critical information – even fatalities, and doing NOTHING but making excuses
for their own behavior:

MHRA has for almost three years been in possession of data showing that
Strattera in many cases actually can cause or worsen the œcondition it is
claimed to alleviate. More than 700 reports were submitted to the manufacturer,
Eli Lilly, about Strattera inducing “œpsychomotor hyperactivity. Lilly called
this an exacerbation of the “œunderlying ADHD”. If we would apply this to
the area of real medicine and to diabetes we could say that the patient got a
diabetes medication with resulting heavy increase in blood sugar level. Such a
medication would probably be withdrawn very fast from the market. But the
MHRA has not yet, after three years, succeeded to get even a bad quality review
of these cases done not even from the manufacturer.

Do read the rest of the information because it is clearly eye opening!! This
newer ADHD drug, Strattera, which is really an SSRI antidepressant, is
getting away with murder right under everyone’s noses. So definitely if you
know someone who is willing to talk to this news crew about their experience with
this drug, please do let me know ASAP.

Thank you,

Ann Blake-Tracy, Executive Director,
International Coalition for Drug Awareness
_www.drugawareness.org_ (http://www.drugawareness.org/) &
_www.ssristories.org_ (http://www.ssristories.org/)
Author of Prozac: Panacea or Pandora? – Our
Serotonin Nightmare & the audio, Help! I Can’t
Get Off My Antidepressant!!! ()

_atracyphd1@…_ (mailto:atracyphd1@…)

_http://www.newmediaexplorer.org/sepp/2008/10/20/strattera_adverse_effects_uk_
medicines_agency_refuses_to_act.htm#_
(http://www.newmediaexplorer.org/sepp/2008/10/20/strattera_adverse_effects_uk_me\
dicines_agency_refuses_to_act.htm#
)

October 20, 2008
_Print this article_
(http://www.newmediaexplorer.org/sepp/2008/10/20/strattera_adverse_effects_uk_me\
dicines_agency_refuses_to_act.htm#
)

Strattera adverse effects: UK Medicines Agency refuses to act
By Sepp Hasslberger

Categories
_Pharma_ (http://www.newmediaexplorer.org/sepp/pharma.htm)

Janne Larsson, an investigator and reporter in Sweden, has obtained
information about adverse event reports on Eli Lilly’s ADHD drug Strattera,
using the Swedish freedom of information laws. The data, coming from both the FDA’s
adverse reaction database and from reports to the UK’s Medicines agency, shows
numerous adverse effects and scores of deaths by suicide.

Yet the agency, even after repeated prodding by Larsson to initiate action,
has refused to budge or even acknowledge that there is a problem. MHRA
apparently accepts the drug’s producer Eli Lilly’s data rather than its own and
the
FDA’s adverse event reports.

Image credit: _Monheit Law_
(http://www.monheit.com/strattera/contact_lawyer.asp)

Larsson says: An investigation of MHRA™s handling of the harmful effects of
the ADHD drug Strattera has proven the following:

MHRA has ignored data about instances of death among children in connection
with Strattera treatment. At least 41 children have died. The agency has not
investigated the reported cases and does not even have a compiled summary of
cases with fatal outcome. Further the agency has allowed the manufacturer Eli
Lilly to give false information about the number of fatal cases and has
taken no action against the company once the false information was revealed.

MHRA has for almost three years been in possession of data proving that
Strattera can cause agitation, mania and psychotic reactions with hallucinations
among children. Yet no warning has been issued to doctors and parents. The
agency has withheld these disastrous consequences despite clear evidence. Due
to bureaucratic procedures no warnings have been issued even if Eli Lilly reluc
tanly conceded to include these harmful reactions in its information to the
public almost a year ago.

MHRA has for almost three years been in possession of data showing that
Strattera in many cases actually can cause or worsen the œcondition it is
claimed to alleviate. More than 700 reports were submitted to the manufacturer,
Eli Lilly, about Strattera inducing œpsychomotor hyperactivity. Lilly called
this an exacerbation of the œunderlying ADHD. If we would apply this to
the area of real medicine and to diabetes we could say that the patient got a
diabetes medication with resulting heavy increase in blood sugar level. Such a
medication would probably be withdrawn very fast from the market. But the
MHRA has not yet, after three years, succeeded to get even a bad quality review
of these cases done“ not even from the manufacturer.
The background data for these conclusions can be found in the following text
and in the linked documents. When reading the data below please remember the
promise from the MHRA: we take any necessary action to protect the public
promptly if there is a problem._MHRA, About us_
(http://www.mhra.gov.uk/Aboutus/index.htm) [1]

Note that the linked documents (within letters described below) in most
cases could not be obtained in UK where the issuance of them would be deemed as
prejudicing œthe ability of the Assessory body to offer impartial advice and
where the MHRA wants to allow marketing authorisation holders the chance to
respond to regulatory action and make commercial decisions before data are
in the public domain. (MHRA, e-mail about FOIA-request, 29th September,
2006). However the documents could be obtained in Sweden, even if the MHRA has
tried to stop the issuance of them by implying that publication could threaten
the relations between Sweden and UK.
Deaths among children in connection with Strattera treatment

In May I submitted detailed data about cases of Strattera death to the MHRA.
1st October I finally got an answer from the Scientific Assessor of the
Vigilance and Risk Management of Medicines (VRMM). 7th October I got an answer
from Professor Kent Woods, CEO of the MHRA, referring to the letter sent by the
Scientific Assessor.

My data about Strattera deaths can be found _in the letter_
(http://jannel.se/Strattera.death2.pdf) Strattera: Eli Lilly gave false
information about
deaths from Strattera treatment “ a request for full investigation from 15th
May. [2]
The answer from the Scientific Assessor shows that MHRA is continuing to
ignore data about instances of death among children and adults in connection
with Strattera treatment. Despite limited resources and having to rely on data
released by reluctant medical agencies I had been able to produce a summary of
reported cases of Strattera death. Thats much more than the MHRA, with its
immense resources, had been able to do.

The agency was provided with specific data about instances of death forming
an excellent starting point for a full investigation. But instead of using
the data the MHRA used its energy to explain why it is impossible to
investigate these cases further, and in doing so presents some remarkable
comments.

The Scientific Assessor states _in the letter 1st October_
(http://jannel.se/Reply.from%20MHRA.Assessor.October.pdf) [3]:

in order to calculate the total number of reports with a fatal outcome
it is not simply a case of adding up reports with a fatal outcome mentioned
in our assessment reports of the PSURs [Periodic Safety Update Reports] and
those available on the FDA website as these different sources may contain
duplicate information. [Emphasis added.]

I fully agree and it takes only a casual reading of my letter from 15th May
to find out that much care has been taken to exclude possible duplicates. It
is quite easy to see that the data presented about fatal cases in my letter
is NOT simply a case of adding up reports with a fatal outcome. The only
way to come to another conclusion would be not to look in the first place and
it is a condemnation of the effectiveness of the agency to state the following
in the letter:

We have looked at the data you have sent us to see if they can add insight
to the statutory sources of data we have received and do not think that they
are of benefit as we cannot verify their source or accuracy. (p. 3)
[Emphasis added.]

I must add to all the data provided in my letter 15th May that the our

of the information about fatal cases is FDA™s Medwatch system and the PSURs
(submitted directly to the MHRA). I must make it clear that is very easy for
a lay person to find out that almost all reports about fatal outcome from
Strattera treatment submitted to the FDA came from Eli Lilly!

Thus the our of the information about fatal cases was in most of the
cases the manufacturer itself“ Eli Lilly. And yet the MHRA has not been able
to verify the source or accuracy of the information. The MHRA Scientific
Assessor states in the letter:The sources of data that regulators use such
as company data, spontaneous adverse reaction reports and literature are set
out in European and national law.
My FOIA request earlier this year to get a compilation of fatal cases in
connection with Strattera treatment was answered 12th August:

Thats very good and now we know that the data I submitted to the MHRA about
all fatal cases from Strattera treatment “ in the absolute majority of cases
were known by and reported via the manufacturer Eli Lilly.
The MHRA holds no data other than that previously released to you [the
misleading data from Eli Lilly in November 2007, see my letter from 15th May
for
more data] which was the data provided by the company. If you have any
questions about FDA data or the data provided by the company, you should
contact those organisations.

In other words the MHRA didn’t have a compiled summary of cases with fatal
outcome in August and the agency has not to this point been able to compile
such a summary.

As the agency has not been capable of getting the data or not even been
capable of using the specific data submitted for its use in a full
investigation NO action is taken despite the many verified deaths among
children in connection with Strattera treatment. This disregard for the safety of children is a scandal which should lead to a full formal investigation by the
Department of Health.

Drug induced agitation, mania and psychosis with hallucinations

Ive been contacted by parents asking if Strattera can induce mania and
psychosis with hallucinations. Their children have had such symptoms. The
parents have not found any warnings about it and their childrens doctors don’t
think that the symptoms are caused by the drug. The parents were desperate.

However the MHRA has known for almost three years that Strattera can cause
agitation, mania and psychotic reactions with hallucinations among children,
but has refused to issue warnings about it.

The Scientific Assessor from the MHRA _in the letter of 1st October_
(http://jannel.se/Reply.from%20MHRA.Assessor.October.pdf) [3] now confirms my
earlier arguments that the agency had knowledge about these effects a long time ago:

following an initial request in the assessment report for the Periodic
Safety Update for the period (dates 27-05-2005 to 26-11-2005) we asked Eli
Lilly for more information to enable us to review this issue in more detail. (p. 2)

This means that in the period ending 26th November, 2005 at the time when
Strattera was approved only in UK and four other European countries, but not
in the 22 additional European countries where it is now approved Eli Lilly
and the MHRA had knowledge about these disastrous effects in children taking
Strattera. But neither the MHRA nor Eli Lilly told anything about it and
Strattera was approved in 20 additional European countries in April 2006.
Image credit: _Wikimedia Commons_
(http://commons.wikimedia.org/wiki/Image:Strattera_atomoxetin.jpg)

Professor Kent Woods, CEO of the MHRA seems to be very misinformed by his
staff when answering about Strattera in a recent _letter of 7th October, 2008_
(http://jannel.se/answer.kent.woods.pdf) . In the letter Professor Woods
states [4]:

The MHRA is committed to ensuring that all safety concerns are subject to
robust scientific assessment and the best possible regulatory action is taken
in a timely manner. We strive to maintain the highest standards of work and
review our practices to ensure these standards are maintained or improved
upon where necessary. (p. 1)

In their 3rd March, 2006 report Psychiatric Adverse Events Associated with
Drug Treatment of ADHD: Review of Postmarketing Safety Data [5], the FDA
stated that there was compelling evidence for a likely causal association
between [Strattera/amphetamine drugs] and treatment emergent onset of signs and/or
symptoms of psychosis or mania, notably hallucinations, in some patients.

(p. 17) 360 reports about the drug inducing these effects had been received
up to June 2005.

From this FDA report the MHRA had knowledge about the œcompelling evidence for Strattera causing these effects on or about 3rd March, 2006 but did nothing.

In August the same year (2006) the MHRA requested the same data set from Eli
Lilly that was submitted to the FDA and which formed the basis of the FDA
report for Strattera. The data was sent to the MHRA some days later. But the
agency then decided not to do anything with the information. Instead it was
decided that Eli Lilly the manufacturer should do an analysis of the data
and submit its conclusions to the agency.

Professor Kent Woods says in his letter: An important aspect to this [ robust scientific assessment, highest standards] is ensuring that data from all available sources have been consider This may be true in some other area but it is definitely not true for the
safety work around Strattera. A very good example of this is the complete
rejection of the robust scientific assessment of Strattera in the FDA report.
Answering the question why the agency did not use the compelling evidence for harm in the FDA report _an official at the MHRA declared in a letter_
(http://jannel.se/mhraanswer.pdf) [6]:

Changes to European product information are based on assessment by EU
regulators, agreement between member states and in line with legal requirements
about product information, not on conclusions of FDA assessors. (25th May,
2007) [Emphasis added.]

Responsible officials at the MHRA had instead decided to rely completely on
the analysis of the manufacturer of the drug Eli Lilly. (In an article in
the Daily Mail this summer, Andrew Herxheimer, editor of the Drug and
Therapeutics Bulletin, and emeritus fellow of the Cochrane Centre commented:
Asking a drug company to review its own product is crazy, but it goes on quite a lot.
) [7]

At the end of 2007/beginning 2008 Eli Lilly submitted its review of
Strattera induced agitation, mania and psychosis with hallucinations to the
MHRA. It was a complete whitewash.

In summary: FDA was very clear about the psychosis-inducing effects of
Strattera; the MHRA did not listen. Instead the MHRA turned to the
manufacturer. Eli Lilly tried to explain away all the bad results found in its review. For
the full history about MHRA’s failure in this area and for a comparison of
the FDA report with the Lilly report, please see the following letter: _The
ADHD drug Strattera“ actions needed now_
(http://jannel.se/letter.mhra.strattera.jan08.pdf) [8] from January 2008, and
the letter _The ADHD drug Strattera“
an analysis of reports of drug induced mania, psychosis and hallucinations_
(http://jannel.se/strattera.mhra.March.08.pdf) [9] from March 2008.

In the letter from March [9] Eli Lilly’s whitewash report for the period up
to November 2007 is presented. At the end of that report Lilly says [10]:

Nevertheless, Lilly will consider adding language regarding psychotic symptoms
including hallucinations to its product information sheet. (p. 1279)

Larsson – _Suicides & Psychiatric Drugs_
(http://www.newmediaexplorer.org/sepp/suicide.psychiatricdrugs.pdf)

And so we come to October 2008 and the letters from Professor Kent Woods and
from the Scientific Assessor for Strattera. We are reassured that the MHRA
is acting to ensure that Strattera is used as safely as possible that

all safety concerns are subject to robust scientific assessment and the best
possible regulatory action, that any new safety signals are evaluated in
an independent, scientifically robust manner (Woods); we are told that

discussions between European Member States and Eli Lilly are ongoing to agree
on the most appropriate information to be included in the product information
for patients and prescribers; we are told to be patient, to understand that
it takes time from the point where œupdates have been agreed for inclusion in
the product information to the point where these will appear in the packs
in the market place due to movement of stock in the supply chain, and that
the appearances are estimated to be within the next 6 months (Scientific
Assessor).

It is probably hard to find a more obvious violation of the promise¦ we
take any necessary action to protect the public promptly if there is a
problem than the case described above. The worried parents still have no answers if
Strattera can induce the symptoms they find in their children. And the MHRA
knew about it three years ago but withheld the data. This should be
included in the investigation of the agency by the Department of Health.

Strattera causing hyperactivity“ the condition it was supposed to alleviate In my earlier letter to the Department of Health (29th August) I took up the data about the 700 forgotten cases of hyperactivity. I referred to my _letter 2nd January to the MHRA_
(http://jannel.se/letter.mhra.strattera.jan08.pdf) [8] and gave data about the
fact that Eli Lilly had withheld sensitive information and classified harmful effects as an exacerbation of the underlying ADHD.

The logical solution would have been for the MHRA to request all data about
this security risk, followed by an independent review of the data. But this
was not done and as expected nothing is still done. MHRA asked Lilly for an
explanation about this signal stemming from Periodic Safety Update Report
5 (dates 27-05-2005 to 26-11-2005) but got no answer. Three years later the
Scientific Assessor from the MHRA writes in the letter from 1st October:

The information submitted by the MAH [Market Authorization Holder] has been
evaluated and the MAH will be requested to provide further detailed
information within the next 2 months to ensure the issue has been investigated
in a thorough and scientific manner. (p. 2) [3]

The MHRA got this safety signal almost three years ago and is still in
the process of getting some sensible answers from Eli Lilly.

————

I again request the Department of Health to take action. This does not
concern only the children in UK; it concerns the children in the whole of
Europe, indeed it concerns all the children of the world.

The failure of the agency will also mean that psychiatrists within The
Guideline Development Group in NICE can push through more treatment with
Strattera and other ADHD drugs. The MHRA is withholding the clear evidence for
harmful effects and the psychiatrists with close relations to the manufacturers
of the drugs can unimpeded recommend these medicines to unsuspecting
doctors and parents.

The answers given by Professor Kent Woods and the Scientific Assessor did
not in any way handle my concerns. On the contrary, they finally proved that a
full formal investigation of the matters raised above is needed.

Yours sincerely,

Janne Larsson

Reporter – investigating psychiatry
Sweden
_janne.olov.larsson@…_ (mailto:janne.olov.larsson@…)

[1] MHRA, About us, _http://www.mhra.gov.uk_ (http://www.mhra.gov.uk/)
[2] Larsson, Strattera: Eli Lilly gave false information about deaths from
Strattera treatment“ a request for full investigation, May 15, 2008,
_http://jannel.se/Strattera.death2.pdf_ (http://jannel.se/Strattera.death2.pdf)
[3] MHRA, Re: letter of 9th September 2008 to “Assessor responsible for
Strattera, October 1, 2008,
_http://jannel.se/Reply.from%20MHRA.Assessor.October.pdf_
(http://jannel.se/Reply.from%20MHRA.Assessor.October.pdf)
[4] MHRA, Re: Open letter to Pr. Kent Woods (10th August 2008), October 7,
2008
_http://jannel.se/answer.kent.woods.pdf_
(http://jannel.se/answer.kent.woods.pdf)
[5] FDA, Psychiatric Adverse Events Associated with Drug Treatment of ADHD:
Review of Postmarketing Safety Data, released March 3, 2006.
_http://www.fda.gov/ohrms/dockets_
(http://www.fda.gov/ohrms/dockets/AC/06/briefing/2006-4210b_11_01_AdverseEvents.\
pdf
)
[6] MHRA, answer FOI request, May 25, 2007,
_http://jannel.se/mhraanswer.pdf_ (http://jannel.se/mhraanswer.pdf)
[7] Daily Mail, Heart attacks and suicides… yet the dangers were all kept
so quiet. So how CAN you trust your medicine? July 7, 2008,
_http://www.dailymail.co.uk/_
(http://www.dailymail.co.uk/health/article-1033132/Side-effects-include-suicide-\
heart-attacks-So-prescribed-drugs.html
)
[8] Larsson, The ADHD drug Strattera – actions needed now, January 2, 2008,
_http://jannel.se/letter.mhra.strattera.jan08.pdf_
(http://jannel.se/letter.mhra.strattera.jan08.pdf)
[9] Larsson, The ADHD drug Strattera – an analysis of reports of drug
induced mania, psychosis and hallucinations, March 9, 2008,
_http://jannel.se/strattera.mhra.March.08.pdf_
(http://jannel.se/strattera.mhra.March.08.pdf)
[10] Eli Lilly, Cumulative review of Spontaneous Case Reports of Mania,
Psychotic Disorders, Hallucinations, and Agitation, Appendix 16 to Periodic
Safety Report 9 for Strattera, 2008,
_http://jannel.se/Lilly_psychosis_strattera.pdf_
(http://jannel.se/Lilly_psychosis_strattera.pdf)

See also:

_Doctors told to curb use of Ritalin in hyperactive children_
(http://www.timesonline.co.uk/tol/news/uk/science/article4813727.ece)
_Children’s suicide attempts raise concerns about ADHD medication_
(http://www.theglobeandmail.com/servlet/story/RTGAM.20080703.wadhd03/BNStory/spe\
cialScie

nceandHealth/home)
_The ADHD drug Strattera: Lilly to issue warnings about psychosis,
hallucinations, mania and agitation_ (http://jannel.se/strattera.psychosis.doc)
_Strattera side effects_ (http://www.bonkersinstitute.org/stratteraffex.html)

_Strattera – 10,988 adverse “psychiatric reactions” reported in less than
three years_ (http://www.24-7pressrelease.com/view_press_release.php?rID=16662)
_Attention Deficit Hyperactivity Disorder? No, they’re just naughty, say
experts_
(http://www.dailymail.co.uk/news/article-1031436/Attention-Deficit-Hyperactivity\
-Disorder-No-theyre-just-naughty-say-experts.html#
)

508 total views, no views today

4/29/2001 – NY-CITY AGENCY'S PSYCH DRUGS IMPERIL FOSTER KIDS

About three years ago the Seattle Times or the Seattle PI did a series of
articles on the drugging of foster children and the number of deaths as a
result of that deadly practice. Now the New York Post has given us another
article detailing the same problem in the East. Several years ago I learned
that we too have the problem here in the Rocky Mountain area.

My children are adopted and they have always wanted a younger brother or
sister. We looked for several years for a child we could make a part of our
family. We were not able to find one available that was not being drugged for
a variety of reasons. I asked an agency if they had any children available
who were not on drugs, explaining that drug withdrawal is not where I would
want to begin a relationship with a child.

The woman at the agency lowered her voice and said, “Isn’t it horrible?! We
have a doctor in charge here who is drugging all of these children and there
is nothing we can do about it!”

In my opinion, to do this to the most helpless among us – a child alone with
no family to protect them from the drugging – is the most damning statement
against our society there is.

In the news this past weekend we all heard about tragic death of an adopted
child, little Candace Newmaker, who died during a controversial “rebirthing”
therapy in Colorado. She was being given this “treatment” for the diagnosis
of “attachment disorder.” As you read about her death you learn that the
expert witness in this case could not say if it was the therapy that caused
her death or the drugs – Rispirdol being taken at her death AFTER a long
period of treatment with antidepressants. Because the increase in serotonin
shuts off the bronchial tubes it can produce death by asphyxiation – the
cause of death in Candace’s case. We also know that when the serotonin is
increased to too high a level by these drugs it leads to Serotonin Syndrome
which includes multiple organ failure.

Now I invite you into Candace’s drug-induced world – the same world which you
will see was obviously what produced the symptoms that led her and her
desperate adoptive mother into this controversial therapy. As you read the
list of symptoms of increased serotonin and decreased serotonin metabolism in
the document on our site called The Aftermath
(http://drugawareness.org/Archives/Miscellaneous/MRAfter.html) you will see
everyone of the side effects Candace was having that left her mother reeling
from the experience.

Excerpts from the Denver Rocky Mountain News:

* When the local social services workers contacted her with information
about Candace, she was told the girl had a “strong temperment,” that she was
prone to uncontrollable outbursts. Candace had been through six foster homes
by the time she was five, and her birth family had neglected her, Newmaker
was told.

* One night in the spring of 1999, Newmaker woke at 2:30 a.m. and smelled
smoke, she said. She ran down the hall to Candace’s room, but it was empty.
She opened the next door to the guest room and found her daughter.

* “She was sitting on the bed in the guest room with spent matches all
around her,” Newmaker said, crying. “I’m so frightened for her. She could
have hurt herself, killed herself.”

* Speaking publicly for the first time about Candace’s death during that
therapy, Jeane Newmaker said her daughter’s psychological problems were so
advanced that she started a fire in their home, once sexually assaulted two
children, and would fly into hourlong rages.

* “I thought she was deteriorating before my very eyes,” Newmaker said. “I
was not prepared for the level of dysfunction I saw in Candace.”

Ann Blake-Tracy, Executive Director,
International Coalition For Drug Awareness
www.drugawareness.org

http://www.nypost.com/commentary/28629.htm

CITY AGENCY’S PSYCH DRUGS IMPERIL FOSTER KIDS

By DOUGLAS MONTERO
——————————————————————————

MOTHER’S NIGHTMARE:
Erline Kidd, with sons Devon (left) and Von, is fighting to stop the city
from medicating her little girl, who’s in foster care. “My daughter is like a
zombie,” she says.
– Yechiam Gal

April 16, 2001 — ERLINE KIDD doesn’t want her 8-year-old daughter to end up
like a boy named Cecil Reed – a corpse at the city morgue.
Kidd fears for the life of her daughter Shaevonnah – “Shae” – because she’s
in the custody of the city’s Administration for Children’s Services – just
like Cecil was.

And just like Cecil, ACS is allowing doctors to give Shae a cocktail of
psychiatric medications that Kidd feels is harming her baby.

Kidd’s objections are being ignored, just like those of Cecil’s father, who
stopped complaining April 7, 2000, when his 16-year-old son suffered a heart
attack triggered by a combination of four drugs, and died.

“I was begging them to stop,” said Cecil Reed Jr., a city worker who lives in
The Bronx.

“Jesus,” said Dr. Peter Breggin, an author and critic of psychiatric
treatment of children. “They were treating him like you would treat a raving
psychotic.”

ACS says it doesn’t know how many of its 31,000 children are on psychiatric
medication, but advocacy groups say complaints from parents arrive at their
offices on a “regular basis.”

A state audit of 401 randomly selected kids last year found that more than
half were being treated for mental problems – and that most likely means
medication.

Some advocates charge the foster-care agencies contracted to care for nearly
90 percent of ACS’s children use medication to “control” the emotionally
troubled kids.

Parents like those of Tariq Mohammad, 16, face medical-neglect charges in
Family Court if they object too vigorously.

Tariq was on medication for schizophrenia, an illness he says he never had,
and its side effects made him violently ill. The family sued ACS in civil
court and won after a court-appointed psychiatrist determined Tariq didn’t
need any medication.

“I am outraged, not just for me, but for many kids that are being medicated,”
Tariq said. “It really screwed me up. I guess they do it because they don’t
want to deal with us.”

Tariq, who lived in the foster system since he was 11, says his pleas for an
alternative treatment were summarily ignored.

The ACS says parents are entitled to get a second medical opinion or hire a
lawyer to fight the case in court.

The mad rush to medicate, a nationwide phenomenon, is especially delicate
with foster kids. The ACS relies on the judgment of doctors subcontracted by
its 60 foster agencies to evaluate and treat children, agency spokeswoman
Jennifer Faulk said.

The ACS is supposed to monitor the treatment, but overworked caseworkers
can’t – or don’t – micromanage each kid, so they defer to doctors.

Hank Orenstein, the director of the advocacy agency C-Plan, said the ACS
exhibits a “naivete” in mental-health services.

“It’s a relief to have other professions make the decision but as you can see
some children are not always best served with medication,” said Orenstein,
whose group is part of Public Advocate Mark Green’s office.

Parents end up becoming helpless watchdogs handcuffed by bureaucracy and
poverty.

“I hated it,” said Cecil Reed’s father, a Baptist church deacon, describing
the slow medication death of his son at the Bronx Children’s Psychiatric
Center.

Reed began noticing a problem with Cecil’s treatment three years before his
son died. Reed, who was threatened with medical-neglect charges, said Cecil
was “sleepwalking” after the hospital began serving the boy cocktails.

Doctors said Cecil had schizoaffective disorder and post-traumatic stress
disorder but his father claims his son wasn’t insane, just a strong-willed
kid who like any youngster would lash out after being separated from family
and friends.

“Daddy, I don’t want to take medicine anymore . . . They are just using me as
a guinea pig,” Reed remembers his son saying.

When the usually cooperative Reed questioned the medication in late 1999, the
hospital simply got consent from the ACS behind the father’s back, he
charged. Faulk didn’t respond to the allegation.

He learned about the deadly cocktail the day after his son died.

The autopsy report notes Cecil’s body contained “potentially toxic” levels of
pindolol, a heart-damaging drug never tested or recommended for children.

Breggin said serving these cocktails to children is “so dangerous and
experimental that it wouldn’t be permitted under any legitimate rule of
research.”

The ACS, the state’s Office of Children and Family Services and the state
Office of Mental Health, which runs the Bronx facility where Cecil died,
refused to comment because the family plans to sue.

Erline Kidd’s face sunk when she was told about Cecil. Kidd charged she
always learns about the drug cocktails her daughter gets after the fact. All
contact with her daughter’s doctor is arranged by the ACS.

Kidd, a reformed cocaine addict, is fighting two wars: to get her daughter
back from the ACS, like she did with her two sons, ages 12 and 9, in January,
and to stop the drugging of the girl.

Little Shae is on Seroquel and Thorazine for psychosis, and four other drugs.

“I just know it’s too much – my daughter is like a zombie,” the mother said.
“One time I saw her and I wanted to grab her and run.”

638 total views, no views today

3/24/2001 – 5 Drug Makers Use Material With Possible Mad Cow Link

We have heard much about Mad Cow disease (Creutzfeldt-Jakob disease) lately.
Little of what we have heard comes close to truth about the spreading of mad
cow in America. Two major news shows, 20/20 and 60 Minutes, have covered this
issue in the last couple of weeks. 60 Minutes came a little closer to the
truth than 20/20.

I could not understand why the 20/20 segment was asking if we have Mad Cow in
America and the 60 Minutes segment stated we do not have any cases here yet
when we have known for some time that Mad Cow disease (Creutzfeldt-Jakob) is
in this country. In fact the CDC came to Utah about three years ago to
investigate several deaths from Mad Cow that we had in one year – one was the
man featured in the 20/20 segment. Another of the deaths was a city official
whose death gained much public attention and generated several local news
stories on mad cow. Then while I was in Arizona in October I ran across an
article from a Tucson paper that discussed the wife of an attorney who died
of Mad Cow disease (Creutzfeldt-Jakob disease) in September, 2000. The
article stated that her death was the SECOND death from Creutzfeldt-Jakob
disease in Tucson alone this year. Consider this information when we know
that France’s Mad Cow scare was generated by two mad cow deaths in one year
for the whole country. When you compare France’s cases of CJD against their
population base with Tucson’s two deaths in one city in one year and Utah’s
cases with a population base of only about 1 million you get some idea of the
magnitude of this problem in America.

Several months ago I sent you an article from the LA Times (still archived in
our e-group, entitled “A Wonder Drug That Carried the Seeds of Death”). The
article featured the high number of deaths among patients involved in a
National Institutes of Health study conducted in the early 80’s. They found
that 25% of the patients involved who received a growth hormone in this
project are now dying of Mad Cow disease. Now, in case you missed it last
month, the New York Times revealed that five drug companies have been using
material that may have been tainted with Mad Cow. The warnings and drugs
involved are listed in the articles below. Most patients are unaware of how
many animal products are contained in medications.

Isn’t it interesting that 20/20 nor 60 Minutes did not even hint at this
issue in their show on Mad Cow disease in America? Even our local ABC station
here went on after the 20/20 piece to assure us that we have safe meat in
Utah when it was the same station who ran a piece a couple of years ago on
the city official who died of Mad Cow.

Keep in mind as you read how remote they estimate the possiblity of
contracting Mad Cow from these drugs is, that they told patients who took
Fen-Phen and Redux that their possibility of contracting Primary Pulmonary
Hypertension was about the same. Those now suffering PPH would certainly tell
you that it was never worth the risk.

In light of this information I sure do hope you didn’t get your flu shot!

This whole Mad Cow issue is a lesson in how stupid it is to take an animal
that is strickly vegitarian and turn them into a canibal just because it will
make them grow faster and bring in the big $$$ faster. As the LA times
pointed out in an article in this past Sunday’s edition, quoting Dr. Neal
Barnard who heads the Physician’s Committee for Responsible Medicine, in
light of the wide numbers of diseases that come from eating animal products
it is time for us all to seriously consider vegitarianism. In light of the
following article he should also include avoiding medications.

Ann Blake-Tracy, Executive Director,
International Coalition For Drug Awareness
www.drugawawerness.org

February 8, 2001 Single-Page Format

By MELODY PETERSEN and GREG WINTER

——————————————————————————

For the last eight years, the Food and Drug Administration has repeatedly
asked pharmaceutical companies not to use materials from cattle raised in
countries where there is a risk of mad cow disease.

But regulators discovered last year that five companies, including some of
the world’s largest drug concerns, were still using ingredients from those
countries to make nine widely used vaccines.

Some of the companies say that they found the F.D.A.’s request unclear and do
not believe they did anything wrong. Others say they could not keep up with
the government’s expanding list of countries where cattle could be infected.
One, however, acknowledged that it could have moved more quickly.

The nine vaccines include some regularly given to millions of American
children, including common vaccines to prevent polio, diphtheria and tetanus.
They also include the anthrax vaccine, which the government requires for
soldiers serving in the Persian Gulf.

Federal health officials stress that the vaccines are still considered safe.
They calculate that the odds of these vaccines passing on the disease, in the
worst eventualities, are between one in 40 million and one in 40 billion
doses.

The officials say that the very slight chance that someone could be infected
is far outweighed by the benefits that these vaccines bring in fighting
disease and preventing death. Indeed, it is now only a scientific theory that
a vaccine could infect someone with the human form of mad cow disease called
new variant Creutzfeldt- Jakob disease. No one is known to have contracted
the disease this way.

“Any risk is very remote,” said Dr. Karen Midthune, director of the F.D.A.’s
Office of Vaccine Research and Review. “But if we have the ability to bring
this remote risk to zero, that is something we want to do.”

Nonetheless, the fact that these suspect materials slipped into the nation’s
vaccine supply and that the F.D.A. did not discover it for seven years
raises questions about the agency’s ability to ensure that all medicines are
free of the infectious proteins that can cause mad cow disease.

The F.D.A. so far has only investigated the vaccine makers and has not looked
to see whether other medicine is free of possible mad cow contaminants. Some
experts say they worry more about dietary supplements. Unlike drugs,
supplements are largely unregulated. The F.D.A. is not even sure how many
supplement makers there are.

“It’s just insane not to have greater safeguards” for supplements, said Dr.
Paul W. Brown, chairman of the F.D.A.’s advisory committee on mad cow
disease. “The potential exists for abuse.”

All five vaccine makers, which include GlaxoSmithKline, Aventis and American
Home Products, have now agreed to stop using the suspect materials, which
include blood, fetal calf serum and meat broth.

But it will take a year or more to replace existing supplies with
reformulated products, because it can take many months to grow cultures used
in making vaccines. Both the companies and the F.D.A. say that the current
products are safe and should remain on pharmacy shelves.

They point out that the suspect ingredients, for the most part, are used only
in the early stages of manufacturing, when cultures are grown. Blood, for
instance, may be used to feed the bacteria and viruses in these cultures. The
cultures are then significantly diluted in the final vaccine.

http://www.nytimes.com/2001/02/08/health/08CONS.html

February 8, 2001
The Vaccines in Question

——————————————————————————

An outside committee of health experts and federal regulators has reviewed
the risk of contracting the human equivalent of mad cow disease from several
vaccines and has concluded that the risk is remote and only theoretical. No
one is known to have been infected by a vaccine. The United States Public
Health Service said in December that all people should continue to be
vaccinated. The service said there was no need to select one vaccine over
another.

The Food and Drug Administration calculates that at the worst the risk of
contracting the disease from one dose of a bacterial vaccine, such as a
vaccine to protect against tetanus, is one in 40 million.

And with viral vaccines, like the one against polio, the F.D.A. estimates
that the risk is far lower no more than one in 40 billion.

More information is available on the Web at www.fda .gov/cber/bse/bse.htm.

Here is the list of vaccines that use cattle materials from countries where
the government says there is a risk of mad cow disease:

ActHIB, sold by Aventis Pasteur, to prevent infection by the haemophilus
influenzae Type B bacterium.

OmniHIB, sold by GlaxoSmithKline, to protect against haemophilus influenzae
Type B.

Infanrix, sold by Glaxo SmithKline, to prevent diphtheria, tetanus and
pertussis.

Havrix, sold by GlaxoSmithKline, to prevent hepatitis A.

Certiva, sold by North American Vaccine, now a unit of Baxter International,
to prevent diphtheria, tetanus and pertussis.

Vaccines that use cattle materials of unknown geographic origin are:

IPOL, sold by Aventis Pasteur, to prevent polio.

Pnu-Imune 23, sold by American Home Products’ Lederle Laboratories, to
prevent pneumococcal diseases.

Anthrax vaccine, sold by BioPort.

Rabies vaccine, sold by BioPort.

482 total views, no views today

4/17/2000 – Heat deaths related to medication raised

The inability to handle heat has been a common report from
patients for years with the serotonergic medications. Many
patients also find that it continues after coming off the
medication. Now the Dallas Morning News brings us some
insight into the dangers of that reaction.

Ann Blake-Tracy
————————

Heat deaths related to medication raised
Dallas Morning News (April 17, 2000).

DAYTON, Ohio – Findings from health authorities have doubled
the number of deaths related to psychiatric medications taken by
the mentally ill during last summer’s fierce Midwestern heat
wave.

New figures from the U.S. Centers for Disease Control and
Prevention in Atlanta and the Cook County medical examiner’s
office in Chicago show that at least 23 of the estimated 300 dead
were mentally ill people who took medicines that made them
especially vulnerable to death from intense summer heat.

The total could be higher because not all coroners where heat
deaths occurred performed toxicology tests. The medications
interfere with the body’s thermo-regulatory system, hazards
known to physicians but seldom publicized.

Common drugs included Mellaril, Elavil, Prozac and Zoloft.

696 total views, no views today